4631 - 4640 of 9145 Results
Title
Year
-
OPENTitle: CLIPPERS: A Treatable Cause of Spastic AtaxiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 212End Page: 214Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12602Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12602Citation Count: 2
-
OPENTitle: Structural model of the dimeric Parkinson’s protein LRRK2 reveals a compact architecture involving distant interdomain contactsJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 113Issue #: 30Start Page: E4357End Page: 66Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1523708113Best OA location URL: https://www.pnas.org/content/pnas/113/30/E4357.full.pdfCitation Count: 155
- A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults2025OPENTitle: A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adultsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 7Start Page: 1253End Page: 1263Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251356503Best OA location URL: https://doi.org/10.1177/1877718x251356503Citation Count: 2
-
OPENTitle: An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 alleleJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 127Issue #:Start Page: 278End Page: 286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2019.02.023Best OA location URL: https://doaj.org/article/6a674f9f412742f7840d1c3d8f970659Citation Count: 35
-
OPENTitle: Importance of the Brain Angiotensin System in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 14Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/860923Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/860923.pdfCitation Count: 29
- Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease2023OPENTitle: Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 899End Page: 903Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29342Best OA location URL: https://doi.org/10.1002/mds.29342Citation Count: 20
- Vocal tics in Tourette's syndrome2016RESTRICTEDTitle: Vocal tics in Tourette's syndromeJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 15Issue #: 3Start Page: e1End Page: e1Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(16)00021-1Citation Count: 5
-
OPENTitle: Subcortical Shape Changes, Hippocampal Atrophy and Cortical Thinning in Future Alzheimer's Disease PatientsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page: 38End Page: 38Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2017.00038Best OA location URL: https://doi.org/10.3389/fnagi.2017.00038Citation Count: 65
-
OPENTitle: Sorting (Nexin-13) out Novel Insights into Endolysosomal Cholesterol ExportJournal Name: ContactPublisher: SAGE PublicationsVol: 5Issue #:Start Page: 251525642211145End Page: 251525642211145Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/25152564221114513Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/25152564221114513Citation Count: 2
- Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's disease2019OPENTitle: Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 402Issue #:Start Page: 81End Page: 85Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.05.009Best OA location URL: https://zenodo.org/record/3873416Citation Count: 6